Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/13712
Title: A Phase 2, Six-Month Safety and Efficacy Study of TransCon hGH Compared to Daily hGH in Pre-Pubertal Children with Growth Hormone Deficiency (GHD)
Authors: Senatorova, Ganna
Chatelain, Pierre
Malievsky, Oleg
Radziuk, Klaudziya
Skorodok, Julia
Abdou, Magdy Omar
Peterkova, Valentina
Vlachopapadopoulou, Elpis
Beckert, Michael
Keywords: TransCon hGH
Pre-Pubertal Children
Issue Date: 1-Apr-2016
Citation: A Phase 2, Six-Month Safety and Efficacy Study of TransCon hGH Compared to Daily hGH in Pre-Pubertal Children with Growth Hormone Deficiency (GHD) / P. Chatelain, O. Malievsky, K. Radziuk, G. Senatorova, Ju. Skorodok, M. O. Abdou, V. Peterkova, E. Vlachopapadopoulou, M. Beckert // Endocrine Society's 98th Annual Meeting and Expo, Boston, April 1–4, 2016. – Режим доступа: http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2016.PE.3.OR31-5.
Abstract: This study demonstrates the safety and efficacy of TransCon hGH in children with GHD over a treatment period of six months. Safety and efficacy (annualized height velocity), as well as PK and PD data of 53 GHD patients treated over a six-month period with TransCon hGH or daily hGH will be presented. All TransCon hGH doses demonstrated an excellent safety (comparable to daily hGH) and local tolerability profile (only mild and sporadic reactions comparable to daily hGH / no nodule formation and lypodystrophy) and an excellent growth within the expected ranges - mean annualized height velocities ranging between 11.9 cm to 13.9 cm for the different dose levels of TransCon hGH compared to 11.6 cm mean annualized height velocity for daily hGH treatment.
URI: http://repo.knmu.edu.ua/handle/123456789/13712
Appears in Collections:Наукові праці. Кафедра педіатрії № 1 та неонатології

Files in This Item:
File Description SizeFormat 
Endo 2016.pdf246,72 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.